Sustained Cellular and Humoral Immune Responses From an Adenoviral Vector-based Respiratory Syncytial Virus Vaccine

Clin Infect Dis. 2020 May 6;70(10):2082-2083. doi: 10.1093/cid/ciz659.

Abstract

No abstract available

Keywords: adenoviral vector; clinical trial; respiratory syncytial virus; vaccine.